Long Hours at Work Are Costing You More Than Your Social Life
Putting in long hours at the office might impress your boss, but they’re certainly not helping your health.
A new study published in The Lancet found that individuals who worked 55 hours per week or more had a 1-3 times greater risk of a stroke compared to those who worked 40 hours a week. Long working hours were also associated with an increased chance of coronary heart disease, but this association was found to be weaker than that for a stroke.
The analysis was the largest study conducted thus far of the affiliation between working hours and cardiovascular health, including data on more than 600,000 individuals in Europe, the U.S., and Australia.
Researchers believe the constant triggering of the stress response from overwork induces the stroke, often resulting in sudden death. In addition, behavioral activities that stem from the longer hours also contribute to the heightened chance of a stroke.
Employees who work longer hours are found to rely more on heavy alcohol consumption as a way to reduce stress, but drinking only increases the risk for all types of strokes. In addition, more time at a desk means long periods of physical inactivity, which can increase the risk of stroke.
A study by Credit Loan shows that employees worldwide are working more than 40 hours per week. The U.S. leads the pack with the highest percentages of overtime workers – 85.8 percent of males and 66.5 percent of females.
Someone ought to tell Jeb Bush before he repeats what he said early in the campaign -- that Americans need to put in more hours at work.
Tax Refunds Rebound
Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion
The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.
